Related stories
Aarti Drugs Q2 Consolidated Revenue INR 8,262.4 Million
M impact | EQUITY | Nov 03, 2026, 01:39 PM UTC
Aarti Drugs Q2 Consolidated Net Profit INR 827.7 Million
M impact | EQUITY | Nov 03, 2026, 01:39 PM UTC
Absolent Air Care operating profit rises 10% in Q3
M impact | EQUITY | Nov 03, 2026, 01:39 PM UTC
Expeditors Reports Higher Q3 2026 Earnings Per Share and Revenue
Expeditors reported higher earnings per share and revenue for Q3 2026.
M impact | EQUITY | Nov 03, 2026, 01:39 PM UTC
Europe’s Stoxx 600 turns positive, up 0.2%
M impact | EQUITY | Nov 03, 2026, 01:39 PM UTC
Fusemachines Q3 2026 Net Loss More Than Triples to USD 4.62 Million
M impact | EQUITY | Nov 03, 2026, 01:38 PM UTC